Week On Wall Street
  • Home
  • Personal Finance
  • Investing
    • Investing
    • Advisors
    • Investor Tips
  • Earnings
  • Taxes
  • Real Estate
  • Retirement
  • Business
    • Business
    • Small Business
  • Finance
    • Finance
    • Wealth
  • Privacy Policy
    • DMCA / Copyrights Disclaimer
    • Terms and Conditions
Skip to content
  • Personal Finance
  • Investing
    • Investing
    • Advisors
    • Investor Tips
  • Earnings
  • Taxes
  • Real Estate
  • Retirement
  • Business
    • Business
    • Small Business
  • Finance
    • Finance
    • Wealth
  • Privacy Policy
    • DMCA / Copyrights Disclaimer
    • Terms and Conditions
Investor Tips
When it comes to markets, don’t listen to the blind man holding the pachyderm’s derivatives.

Articles You May Like

Top Stock Picks for Week of October 6, 2025
Zacks Strategist Shaun Pruitt Discusses the Surge in First Solar (FSLR) Stock
This Week’s 5 Important Earnings Charts
3 Red-Hot Growth Stocks for Your Watch List

Newsletter

Recent Articles

  • 3 Red-Hot Growth Stocks for Your Watch List
  • Zacks Strategist Shaun Pruitt Discusses the Surge in First Solar (FSLR) Stock
  • This Week’s 5 Important Earnings Charts
  • Top Stock Picks for Week of October 6, 2025
  • Buy First Solar Stock for Value, Growth, and AI Energy Upside
  • Zacks Strategist Shaun Pruitt Discusses The Real Trump Trade
  • Pandemic Stock Winners Shopify, Peloton and Zoom: Buying Opportunities in 2025?
  • Astera Labs (ALAB) and Cracker Barrel Old Country Store (CBRL): 10/6/25 Bull & Bear
  • 3 Top Stocks That Aren’t the Mag 7
  • Tesla Beats Delivery Expectations, Stock Sells Off

Earnings

  • Super Micro Computer shares surge 19% after company files delayed financials by deadline
  • Here’s why Home Depot remains a buy after retailer clears lowered earnings bar
  • Lucid CEO steps down; EV maker plans to more than double production in 2025
  • Workday beats estimates for revenue and profit, stock jumps
  • Chegg sues Google for hurting traffic with AI as it considers strategic alternatives

Business

  • Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
  • Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
  • Home Depot earnings beat Wall Street estimates, as retailer breaks comparable sales losing streak
  • How digitally native companies like Rothy’s are growing profitably in a new era for retail
  • Starbucks to lay off 1,100 corporate workers as sales sag

Useful Links

  • DMCA / Copyrights Disclaimer
  • Terms and Conditions
  • Whitelist Us
  • Privacy Policy

Copyright © 2025 by Week On Wall Street. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified.

Powered by WordPress using DisruptPress Theme.